In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 472 for your search:
Drug:  vinblastine sulfate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: EORTC-30944
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000068525, EORTC-GU-30986, NCT00014274
3.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75100
4.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1583
5.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 15 and over
Sponsor:
Protocol IDs: MDA-MBDT-8085
6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8107
7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: under 55
Sponsor:
Protocol IDs: UCLA-81107522, NCI-V83-0180
8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: any age
Sponsor: NCI
Protocol IDs: MSKCC-87102, NCI-T87-0235C, T87-0235
9.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: HOG-GU93-1, NCI-V94-0424
10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 15 to 69
Sponsor:
Protocol IDs: CRC-TU-HO3001, EU-93029
11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other
Protocol IDs: CDR0000063579, FRE-IT94, FRE-FNCLCC-IT94, NCI-F94-0019, NCT00002566
12.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000063640, RTOG-9410, NCT01134861
13.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21 at diagnosis
Sponsor: NCI
Protocol IDs: CCG-5942
14.

Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-8008
15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: any age
Sponsor:
Protocol IDs: MRC-LU20, EU-95041
16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-75104
17.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000065002, FRE-IALT, EU-96010, NCT00002823
18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI, Other
Protocol IDs: DM95-231, P30CA016672, MDA-DM-95231, NCI-G96-1044, CDR0000065105, NCT00002855
19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 10 to 70
Sponsor: NCI, Other
Protocol IDs: ID95-196, P30CA016672, MDA-ID-95196, MDA-DM-95196, NCI-G96-1089, CDR0000065188, NCT00002882
20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: MRC-LU22, EORTC-08012, EU-97016, ISRCTN25582437, NCT00003159
21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-55954, MRC-CE04, COSA, EU-98061, NSGO-CC-9502, NCT00003209
22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Adult
Sponsor:
Protocol IDs: LLCG-BLT, MRC-BLT, EU-98003, NCT00003240
23.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Not specified
Sponsor:
Protocol IDs: MRC-UKLG-LY09, EU-98020, NCT00003421
24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Any age
Sponsor: NCI
Protocol IDs: E-1897, NCT00003701, E1897
25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: ICRF-95.240, EU-99017, NCT00004209
1     
New Search